Atlas Trials

Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors

Clinical trial NCT05981235 · COMPLETED

Trial details

NCT number
NCT05981235
Sponsor
Peking University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastrointestinal Tumors
Start date
2023-12-14
Primary completion
2025-06-25
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.